Dow Jones 10472.15 +13.26 9:06 am PST, January 12, 2004  NASDAQ 2101.54 +14.62 For info, visit access.smallcapnetwork.com S & P 500 1124.79 +2.93 To be removed, please click here Russell 2000 578.44 +3.24 VOLUME 04: ISSUE 2  Profit Alert: Biophan; Nothing short of breathtaking. I love it when a plan comes together. On December 19th-- barely a month ago-- we alerted readers to an extremely unique nanotech biotechnology concern, Biophan (OTCBB: BIPH) at 35 cents. Monday morning, the shares hit $1.50--a 328 percent return in less than a month!  Time to sell some. Suggested strategies depending on your purchase price and risk orientation: Sell a partial position, say half, and wait for lower prices to re-establish your position as the froth dies down. At the very least, sell enough shares to pay for your initial investment. That means whatever you have left will have cost you nothing--you are now trading on profit. If you can't stand the heat, and your purchase cost is in the mid-double digits, sell your whole position. Given that the shares have moved extremely quickly on massive volumes, we feel that a partial profit alert--at least-- is prudent. Technically, the shares would warrant re-entry at the 90-cent level. Volumes have been massive over the last week and there is obviously good distribution. Taking advantage of the run only makes sense for those investors who heeded our Alert in December. We would strongly suggest retaining some exposure to Biophan. Given the movement of the shares of late, there will certainly be more excitement to come. The exposure the company has to the explosive field of nanotechnology and the business acumen it has already shown makes Biophan a great bet long-term for risk oriented investors. As the company builds out its biotech patent portfolio it will--and frankly has already -- become a force to be reckoned with. In conclusion, we still like Biophan and its prospects very much. However, we also like profits. We will bring readers more details on the company as they develop. For now, take some profits.   We Value Your Feedback Got comments, questions or suggestions? Send 'em on over: Editor@smallcapnetwork.com Unsubscribe Here D I S C L A I M E R : The SmallCap Digest is an independent electronic publication committed to providing our readers with factual information on selected  publicly traded companies. SmallCap Digest is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward  maximizing the upside potential for investors while minimizing the downside risk, whenever possible.  Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features for the publication and circulation of the SmallCap Digest or representation on SmallCapNetwork.net.  Likewise, this newsletter is owned by TGR, LLC.  To the degrees enumerated herein,  this newsletter should not be regarded as an independent publication. Click Here to view our compensation on every company we have ever covered, or visit the following web address:  http://access.smallcapnetwork.com/compensation_disclosure.html for our full compensation disclosure and http://access.smallcapnetwork.com/short_term_alerts.html for Trading Alerts compensation and disclosure. TGR Group LLC has been paid a fee of $25,000 directly by Biophan Technologies, Inc. for reporting on the Company. All statements and expressions are the sole  opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities  mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein. The editor, members of the editor's family, and/or entities with  which the editor is affiliated, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter. The profiles, critiques, and other editorial content of the SmallCap Digest and SmallCapNetwork.net may contain forward-looking statements relating to the expected capabilities of the companies mentioned herein. THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN  SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN  CONSENT OF THE EDITORS OF SMALLCAPNETWORK.NET. We encourage our readers to invest carefully and read the investor information available at the web sites of  the Securities and Exchange Commission ("SEC") at http://www.sec.gov and/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at  http://www.sec.gov/consumer/cyberfr.htm . Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.